Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: A retrospective analysis of the radiumhemmet data, 1980-1995
S. Friesland et al., Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: A retrospective analysis of the radiumhemmet data, 1980-1995, INT J RAD O, 45(5), 1999, pp. 1259-1266
Citations number
29
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Onconogenesis & Cancer Research
Journal title
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Purpose: This retrospective study was done to determine the outcome of pati
ents with tonsillar carcinoma treated at Radiumhemmet, Karolinska Hospital,
between January 1980 and December 1995 with radiotherapy alone or in combi
nation with surgery. In addition the importance of tumor remission for pati
ent survival was analyzed.
Methods and Materials: The analysis is based on 167 previously untreated pa
tients with biopsy-proven, invasive tonsillar squamous cell carcinoma of th
e tonsillar region. All patients were consecutively admitted to the Departm
ent of General Oncology, Radiumhemmet, and treated with curative intent. Th
e median follow-up time was 20 months. The median target dose was 64 Gy, de
livered in fractions of 2 Gy 5 times weekly. Twenty-eight percent of the pa
tients underwent surgery of the primary site and/or neck dissection after r
adiotherapy (RT).
Results: The overall local control rate for the whole patient group after r
adiotherapy was 79%. Probability of survival after 5 years for patients res
ponding with complete remission (CR) was 43% and for patients,vith incomple
te response (non-CR) 9%, (p < 0.0001). The survival in the non-CR group tre
ated with combination therapy was 20 months longer than in patients receivi
ng radiotherapy alone (p < 0.0001). There was no statistically significant
difference in prediction of long-term survival when the patient population
was stratified according to tumor differentiation grade, age, sex, nodal st
atus, or treatment time.
Conclusion: The strongest clinical predictor of survival was the degree of
tumor remission after RT. For the non-CR group receiving combination treatm
ent including surgery there was a survival benefit as compared to patients
treated with RT alone (p < 0.0001) although there were few long-term surviv
ors in this patient group. (C) 1999 Elsevier Science Inc.